| RS1801138 |
JAG1
|
Health Risk |
Likely pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS1801145 |
PAH
|
Health Risk |
Conflicting classifications of pathogenicity |
Phenylketonuria, Inborn genetic diseases |
| RS1801147 |
PAH
|
Health Risk |
Likely pathogenic |
Phenylketonuria, Phenylketonuria |
| RS1801152 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Phenylketonuria |
| RS1801155 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity; association; risk factor |
Breast cancer, susceptibility to |
| RS1801161 |
RS1
|
Health Risk |
Pathogenic |
— |
| RS1801170310 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS1801175 |
G6PC1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease due to glucose-6-phosphatase deficiency type IA, Glycogen storage disease |
| RS1801175648 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS1801176 |
G6PC1
|
Health Risk |
Pathogenic |
Glycogen storage disease due to glucose-6-phosphatase deficiency type IA, Glycogen storage disease due to glucose-6-phosphatase deficiency type IA |
| RS1801178 |
CFTR
|
Health Risk |
Likely pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1801182500 |
KCNH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome 1, Long QT syndrome 2 |
| RS1801183 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, type 4 |
| RS1801183828 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Cardiovascular phenotype |
| RS1801206 |
WFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 6, WFS1-Related Spectrum Disorders |
| RS1801208 |
WFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 6, WFS1-Related Spectrum Disorders |
| RS1801214 |
WFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 6, WFS1-Related Spectrum Disorders |
| RS1801214475 |
KCNH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Long QT syndrome 2 |
| RS1801232040 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS1801243 |
ATP7B
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilson disease, Wilson disease |
| RS1801248 |
ATP7B
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilson disease, Inborn genetic diseases |
| RS1801253 |
ADRB1
|
Health Risk |
Benign; association |
Pulmonary disease, chronic obstructive |
| RS1801256 |
BLM
|
Health Risk |
Conflicting classifications of pathogenicity |
Bloom syndrome, Hereditary cancer-predisposing syndrome |
| RS1801265 |
DPYD
|
Health Risk |
Conflicting classifications of pathogenicity |
Dihydropyrimidine dehydrogenase deficiency, fluorouracil response - Toxicity |
| RS1801269 |
ABCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe early-childhood-onset retinal dystrophy, Retinitis pigmentosa 19 |
| RS1801297484 |
CLN8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS1801309834 |
CLN8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS1801327 |
BEST1;FTH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Hemochromatosis type 5 |
| RS1801328287 |
WRN
|
Health Risk |
Pathogenic |
Werner syndrome, Werner syndrome |
| RS1801377 |
FANCI;POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group I, POLG-related disorder |
| RS1801395870 |
CNTNAP2
|
Health Risk |
Pathogenic |
Cortical dysplasia-focal epilepsy syndrome, Cortical dysplasia-focal epilepsy syndrome |
| RS1801396588 |
CNTNAP2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1801406108 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS1801409660 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS1801410644 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome 2 |
| RS1801437299 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS1801442718 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS1801444435 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS1801449253 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS1801462423 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS1801466 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe early-childhood-onset retinal dystrophy, Stargardt disease |
| RS1801505 |
CAPN3
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS1801519418 |
WRN
|
Health Risk |
Pathogenic |
Werner syndrome, Werner syndrome |
| RS1801522729 |
WRN
|
Health Risk |
Pathogenic |
Werner syndrome, Werner syndrome |
| RS1801528197 |
WRN
|
Health Risk |
Likely pathogenic |
— |
| RS1801530173 |
WRN
|
Health Risk |
Pathogenic |
Werner syndrome, Werner syndrome |
| RS1801545 |
KCNQ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Early-infantile DEE |
| RS1801581 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
MACULAR DEGENERATION, AGE-RELATED |
| RS1801591463 |
PKHD1
|
Health Risk |
Likely pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS1801599945 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS1801600694 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS1801626 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
ABCA4-related disorder, ABCA4-related disorder |
| RS1801672516 |
CLN8
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 8 |
| RS1801673 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS1801677859 |
CASP2
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1801678807 |
WRN
|
Health Risk |
Pathogenic |
Werner syndrome, Werner syndrome |
| RS1801681007 |
CLN8
|
Health Risk |
Likely pathogenic |
Seizure, Seizure |
| RS1801695 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS1801696 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS1801697 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS1801698 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS1801700 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS1801703 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS1801710 |
EDNRB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hirschsprung disease, susceptibility to |
| RS1801755635 |
CSNK2B
|
Health Risk |
Pathogenic/Likely pathogenic |
Poirier-Bienvenu neurodevelopmental syndrome, Poirier-Bienvenu neurodevelopmental syndrome |
| RS1801761541 |
CSNK2B
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Poirier-Bienvenu neurodevelopmental syndrome |
| RS180177032 |
BRAF
|
Health Risk |
Pathogenic |
Carcinoma of colon, Carcinoma of colon |
| RS180177033 |
BRAF
|
Health Risk |
Pathogenic |
Carcinoma of colon, Carcinoma of colon |
| RS180177034 |
BRAF
|
Health Risk |
Pathogenic |
Cardiofaciocutaneous syndrome 1, Cardio-facio-cutaneous syndrome |
| RS180177035 |
BRAF
|
Health Risk |
Pathogenic |
Cardiofaciocutaneous syndrome 1, RASopathy |
| RS180177036 |
BRAF
|
Health Risk |
Pathogenic |
Cardiofaciocutaneous syndrome 1, Cardio-facio-cutaneous syndrome |
| RS180177037 |
BRAF
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiofaciocutaneous syndrome 1, RASopathy |
| RS180177038 |
BRAF
|
Health Risk |
Likely pathogenic |
Cardiofaciocutaneous syndrome 1, RASopathy |
| RS180177039 |
BRAF
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiofaciocutaneous syndrome 1, Cardio-facio-cutaneous syndrome |
| RS180177040 |
BRAF
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiofaciocutaneous syndrome 1, Cardio-facio-cutaneous syndrome |
| RS180177041 |
BRAF
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiofaciocutaneous syndrome 1, Cardio-facio-cutaneous syndrome |
| RS180177042 |
BRAF
|
Health Risk |
Pathogenic |
Cardiofaciocutaneous syndrome 1, Inborn genetic diseases |
| RS180177083 |
PALB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS180177084 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS180177085 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS180177086 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS180177090 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS180177091 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS180177092 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group N |
| RS180177094 |
PALB2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS180177095 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS180177097 |
PALB2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS180177098 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS180177099 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS180177100 |
PALB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS180177102 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS180177103 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS180177110 |
PALB2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS180177111 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS180177112 |
PALB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS180177113 |
PALB2
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group N, Fanconi anemia complementation group N |
| RS180177115 |
PALB2
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS180177116 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS180177122 |
PALB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS180177123 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |